Oriot D, Wolf M, Wood C, Brun P, Sidi D, Devictor D, Tchernia G, Huault G
Services de Réanimation Pédiatrique, CHU de Bicêtre.
Arch Fr Pediatr. 1990 May;47(5):357-9.
A severe heparin-induced thrombocytopenia is reported in a child suffering from acute myocarditis. Thrombocytopenia (80.10(9)/l) occurred on day 5 (D5) of heparin therapy which was thus discontinued during 8 hours but reintroduced on the view of a negative platelet aggregation test using standard heparin. On D10, while thrombocytopenia persisted the presence of two intra-cardiac thrombi led to replace standard heparin by low molecular weight heparin (Fraxiparin), associated with vitamin K antagonist (phenindione). On D12, a 3rd intra-cardiac thrombus required immediate discontinuation of Fraxiparin therapy. Platelet aggregation tests performed on D14 were positive in the presence of standard heparin and of low molecular weight heparin, thus demonstrating the existence of thrombocytopenia induced by standard heparin and secondly by low molecular weight heparin. This observation led the authors to discuss the diagnosis and the therapeutic management of heparin-induced thrombocytopenia.
据报道,一名患有急性心肌炎的儿童出现了严重的肝素诱导的血小板减少症。血小板减少症(80×10⁹/L)出现在肝素治疗的第5天(D5),因此在8小时内停用了肝素,但鉴于使用标准肝素的血小板聚集试验呈阴性,又重新开始使用。在D10,尽管血小板减少症持续存在,但发现两个心内血栓,于是将标准肝素换成低分子肝素(速碧林),并联合使用维生素K拮抗剂(苯茚二酮)。在D12,出现第3个心内血栓,需要立即停用速碧林治疗。在D14进行的血小板聚集试验显示,在存在标准肝素和低分子肝素的情况下呈阳性,从而证明存在由标准肝素以及其次由低分子肝素诱导的血小板减少症。该观察结果促使作者讨论肝素诱导的血小板减少症的诊断和治疗管理。